Spinal Segment MRI Perfusion and Diffusion Response to Spinal Manipulation in Low Back Pain Patients
Từ khóa
trừu tượng
Sự miêu tả
Non-specific low back pain (LBP) is a very common condition in developed countries, with a point prevalence between 15% and 30% and a lifetime prevalence of about 70%. As a non-invasive treatment method, high-velocity, low-amplitude spinal manipulative therapy (SMT) is used in the conservative treatment of non-specific low back pain (LBP). Several studies suggest an association with favourable outcome. However, the overall effect size of clinical improvement following SMT remains modest. Most research on the effectiveness of SMT on back pain is conducted on patients suffering from "non-specific" LBP, the diagnosis of which is usually based upon the criterium that pain is not attributed to a recognizable pathology (e.g., infection, tumor, inflammatory diseases, fractures, disc herniations with nerve compression)8. In most of these studies, it is unclear whether patients' diagnoses were based upon more than history and clinical examination. The investigators argue that in the majority of cases, back pain labelled as non-specific might be more accurately labelled as non-specified and does have an attributable source and cause, whether one is able to recognize it or not. Therefore, if the diagnosis of non-specific LBP comprises heterogenic conditions, it is unlikely that patients will respond to one therapeutic modality equally.
Diffusion-weighted MR-imaging (DWI) is an application of magnetic resonance imaging that allows the measurement of water movement within and between tissues and is increasingly being used to study musculoskeletal physiology. Because DWI is sensitive even to small changes in fluid flow, it is potentially valuable in the study of the influence of therapeutic interventions such as manual therapy, exercise, and physical agents on musculoskeletal tissues. Studies using DWI have suggested that changes in diffusion within lumbar intervertebral discs occur in response to joint mobilization, prone press-ups, spinal traction and spinal manipulative therapy.
Intravoxel incoherent motion (IVIM) is a method proposed in 1988 by Le Bihan et al. which extracts microvascular blood flow information from diffusion-weighted imaging acquired at different b-values. It is used to generate separate images of diffusion and perfusion without requiring the injection of exogenous contrast agents. Originally developed in brain studies, it has been used in recent years to study perfusion in musculoskeletal tissue. There is a paucity of research addressing physiological events following a SMT intervention for patients with low back pain. A deeper understanding of local biomechanical and neurophysiological effects of SMT interventions might help refine its utilization and improve its effectiveness.
The purpose of this study is to quantify changes in diffusion and perfusion parameters within the intervertebral disc and paraspinal muscle tissue of a spinal segment receiving a spinal manipulative or sham intervention and to evaluate whether those changes differ in spinal segments with or without degenerative changes in 50 low-back-pain patients.
Additionally, it is of interest to determine the relationships between baseline parameters and changes in diffusion and perfusion as well as the degree of degenerative changes. Post-intervention changes in segmental spinal muscle perfusion will also be investigated. There will be a clinical follow-up immediately after the second MRI and at 1 week,4 and 12 weeks.
The repeatability and diurnal variation of IVIM imaging in quantifying perfusion in musculoskeletal tissues will be assessed by comparing perfusion parameters of 20 controls who will not receive any intervention. The investigators will perform a diffusion- and perfusion-weighted MRI at the beginning of the visit in the morning, which is repeated after approximately 20 minutes of rest (lying supine). Controls will present for an additional MRI approximately 10 hours later in the evening of the same day.
In participants consenting to venipuncture, approximately 8 ml of venous blood will be withdrawn using serum collection tubes, allowed to clot, and then centrifuged. The resulting serum supernatant is stored in aliquots at Balgrist Campus at -80°C. It will be analysed at the end of data collection for pro- and anti-inflammatory markers (e.g. C-reactive Protein, Interleukin 1-beta, Interleukin 6 and Tumor Necrosis Factor) in order to determine the relationship between inflammatory markers and degenerative changes, pain duration, and pain and disability outcomes.
ngày
| Xác minh lần cuối: | 06/30/2019 |
| Đệ trình đầu tiên: | 12/05/2018 |
| Đăng ký ước tính đã được gửi: | 03/14/2019 |
| Đăng lần đầu: | 03/18/2019 |
| Cập nhật lần cuối được gửi: | 07/10/2019 |
| Cập nhật lần cuối đã đăng: | 07/11/2019 |
| Ngày bắt đầu nghiên cứu thực tế: | 03/05/2019 |
| Ngày hoàn thành chính ước tính: | 01/31/2020 |
| Ngày hoàn thành nghiên cứu ước tính: | 11/30/2020 |
Tình trạng hoặc bệnh tật
Can thiệp / điều trị
Other: Patient
Giai đoạn
Nhóm cánh tay
| Cánh tay | Can thiệp / điều trị |
|---|---|
| Sham Comparator: Patient 25 Patients will receive a spinal manipulative therapy Intervention, the other 25 Patients receive a sham Intervention. | Other: Patient The patient lies in sidelying position, with the hip of the upper leg flexed to 90° and the foot of the flexed leg hooked behind the popliteal space of the downside leg. The chiropractor faces the subject at a 45°-angle, fixates the flexed knee with his own knee/thigh. The fingers of the cephalic hand reach under the patient's upper arm to contact the upside lateral surface of the superior spinous process. The fingers of the caudal hand hook down-side aspect of the spinous process, the forearm contacts the patient's buttock and thigh. The cephalic hand thrusts lateromedially and caudocranially, from upside toward downside (push). The caudal hand thrusts lateromedially in the opposing direction, from downside toward upside (pull). SMT is repeated after the patient turns to left side lying. |
| No Intervention: Control No intervention |
Đủ tiêu chuẩn
| Tuổi đủ điều kiện để học | 18 Years Đến 18 Years |
| Giới tính đủ điều kiện để nghiên cứu | All |
| Chấp nhận tình nguyện viên lành mạnh | Đúng |
| Tiêu chí | Inclusion criteria: Patients: 1. Persons over 18 years and under 75 years of age with low back pain of any duration clinically not attributable to "red flags" (infection, trauma, fractures, inflammatory illnesses). 2. Source of LBP clinically at the L4/5 or L5/S1 segment. 3. Duration of LBP is longer than 4 weeks 4. Obtained informed consent. Controls: 1. Persons over 18 years and under 75 years of age who have not suffered from low back pain in the last year and have never experienced low back pain for longer than 7 consecutive days. 2. Obtained informed consent. Exclusion criteria: Subjects are excluded from enrolment if they 1. have undergone prior spinal surgery 2. have undergone facet joint, epidural or periradicular injections in the last 6 months 3. had a spinal manipulative therapy intervention in the past 2 weeks 4. have spinal abnormalities (benign or malignant tumors, congenital abnormalities, isthmic spondylolisthesis) 5. have any contraindication to spinal manipulative interventions or are deemed unable to tolerate SMT to both body sides (e.g. pain attributable to above mentioned red flags, inability to perform side-lying without pain, radiculopathy with motor deficits 6. have any contraindication to MRI (e.g. heart pacemaker, metallic foreign body or claustrophobia) 7. have started a new prescription medication targeting blood circulation within the last 3 months 8. are pregnant or nursing 9. Subjects are excluded from venipuncture if they are known to be HIV-positive or have Hepatitis A, B, or C or have another systemic infection (excludes subjects from venipuncture). No study specific testing for HIV or Hepatitis A, B or C is performed. |
Kết quả
Các biện pháp kết quả chính
1. Apparent Diffusion Coefficient Change [Measured on day 1 during the study]
2. Capillary Perfusion Change [Measured on day 1 during the study]
3. Diffusion Change [Measured on day 1 during the study]
Các biện pháp kết quả thứ cấp
1. Change in Apparent Diffusion Coefficient (Control) [Measured approximately 9 hours after the first MRI, during the study]
2. Change in Capillary Perfusion (Control) [Measured approximately 9 hours after the first MRI, during the study]
3. Diffusion change [Measured approximately 9 hours after the first MRI, during the study]
Các biện pháp kết quả khác
1. Pfirrmann-Grade [Measured on day 1, during the study]
2. Weishaupt-Grade [Measured on day 1, during the study]
3. Inflammatory Parameters (interleukins) [Measured on day 1, during the study, and up to 12 months after]
4. Inflammatory Parameters (CRP) [Measured on day 1, during the study]
5. Inflammatory Parameters (TNF-alpha) [Measured on day 1, during the study]
6. Disability Change [Disability change is assessed at 1 week, 1 month and 3 months follow-up]
7. Pain Change: NRS [Pain change is assessed at 1 week, 1 month and 3 months follow-up]
8. Treatment-related adverse events [Treatment-related adverse events are assessed at all time points during the study, starting from the time of inclusion to completion of 3 months follow up]
